US Stock MarketDetailed Quotes

ABBV AbbVie

Watchlist
  • 170.280
  • +0.370+0.22%
Close Jul 12 16:00 ET
  • 170.300
  • +0.020+0.01%
Post 19:59 ET
300.69BMarket Cap50.68P/E (TTM)

AbbVie Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

AbbVie Earnings Date

Currency: USD

Period

Q2 FY2024 Estimates

Jul 25, 2024

Revenue(YoY)

14.01B

+1.07%
EPS(YoY)

1.63

+42.69%
Analyst Rating

Strong Buy

Jul 13, 2024

AbbVie Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 17 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 14.179B--
Jul 25, 20242024/Q2-- / 14.014B--
Apr 26, 20242024/Q112.310B / 11.936B--
Feb 2, 20242023/Q414.301B / 14.027B--
Oct 27, 20232023/Q313.927B / 13.707B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 14.179B--
Jul 25, 20242024/Q2-- / 14.014B--
Apr 26, 20242024/Q112.310B / 11.936B--
Feb 2, 20242023/Q414.301B / 14.027B--
Oct 27, 20232023/Q313.927B / 13.707B--

Unlock Free Earnings Estimates

AbbVie Earnings Reports

  • AbbVie | 10-Q: Quarterly report

    May 3 11:06 ET

  • AbbVie | 10-K: Annual report

    Feb 20 12:48 ET

  • AbbVie: Q3 2023 Earnings Report

    Nov 6, 2023 13:01 ET

  • AbbVie | 10-Q: Q2 2023 Earnings Report

    Aug 7, 2023 13:10 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 13, 2024

    Strong Buy

    • Buy

      75.00%

    • Hold

      25.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg